Related Experiment Video

Updated: Aug 19, 2026

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation

Séverine Van Slambrouck1, Virinder S Parmar, Sunil K Sharma

  • 1Laboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine, Ghent University Hospital, B-9000 Ghent, Belgium.

FEBS Letters
|March 11, 2005
PubMed

Insights

Tangeretin, a citrus flavonoid, inhibits human mammary cancer cell growth by blocking extracellular-signal-regulated kinases 1/2 (ERK1/2) phosphorylation. This effect is enhanced in T47D cells primed with estradiol.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Tangeretin, a methoxyflavone found in citrus fruits, exhibits anti-cancer properties, including inhibition of human mammary cancer cell growth and natural killer cell-mediated cytolysis.
  • Understanding the molecular mechanisms underlying tangeretin's anti-cancer effects is crucial for its therapeutic development.

Purpose of the Study:

  • To investigate the action mechanism of tangeretin, specifically its effects on intracellular signaling pathways.
  • To determine if tangeretin inhibits extracellular-signal-regulated kinases 1/2 (ERK1/2) phosphorylation and to characterize this inhibition.

Main Methods:

  • Tangeretin's effect on ERK1/2 phosphorylation was assessed in human T47D mammary cancer cells.
  • Dose- and time-dependency of ERK1/2 inhibition were evaluated.
  • The impact of estradiol priming on tangeretin's inhibitory effect was examined.
  • The specificity of tangeretin's kinase inhibition was compared to structural congeners.

Main Results:

  • Tangeretin demonstrated a dose- and time-dependent inhibition of ERK1/2 phosphorylation.
  • Estradiol priming optimally enhanced tangeretin's inhibitory effect in T47D cells.
  • Tangeretin exhibited a narrow spectrum of intracellular kinase inhibition.
  • Inhibition of ERK phosphorylation was not exclusive to tangeretin among its structural analogs.

Conclusions:

  • Tangeretin acts as a small molecule kinase inhibitor with a restricted intracellular inhibition profile.
  • The findings identify tangeretin as a potential agent for targeting ERK1/2 signaling in mammary cancer therapy.
  • Further research into tangeretin's specific kinase targets and downstream effects is warranted.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence09:58

An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence

Published on: May 2, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...